It looks like you're new here. If you want to get involved, click one of these buttons!




tariffs-china-devices-drugsThe proposed tariffs have unsettled the medical device and supply industries, given that a growing number of products, as well as their components, are now manufactured in China. In recent years, as trade groups have noted, Chinese manufacturing of medical equipment has undergone a major shift from throwaway items like surgical gloves to more complicated products like magnetic resonance imaging scanners.
China’s medical device industry has been expanding rapidly. An International Trade Commission report in January said the fastest growth was in sales of implantable orthopedic devices, plates and screws, mostly made of titanium and used for surgery and sports medicine. One analyst estimates that about 12 percent of medical devices imported into the United States come from China
Passing costs on or padding costs may also at play here:...generic drugs that contain Chinese ingredients are manufactured in countries like India, meaning they would not be subject to the tariffs. And brand-name drugs made in the United States are frequently so expensive that the list price often has little connection to the product’s manufacturing cost.
“The cynic in me thinks this is another way for companies to say they need to raise their prices,”
https://www.nytimes.com/2018/04/06/health/trump-tariffs-china-devices-drugs.htmlSeveral companies, including Medtronic and Zimmer Biomet, have orthopedic device factories in China that export goods to the United States. ... Any products shipped from those operations to the United States would be subject to the tariffs. Medtronic declined to comment, saying it was still reviewing the proposal. ...
By Friday [April 6, after the initial announcement on tariffs], the major medical device company stocks had dipped along with the overall market. Medtronic shares were 2.7 percent lower for the week, and Zimmer Biomet was down 2.4 percent.
© 2015 Mutual Fund Observer. All rights reserved.
© 2015 Mutual Fund Observer. All rights reserved. Powered by Vanilla